| Primary |
| Hypertension |
37.5% |
| Product Used For Unknown Indication |
25.0% |
| Blood Pressure High |
8.3% |
| Cardiomyopathy |
4.2% |
| Cerebrovascular Accident |
4.2% |
| Diabetic Nephropathy |
4.2% |
| Essential Hypertension |
4.2% |
| Gestational Hypertension |
4.2% |
| Phaeochromocytoma |
4.2% |
| Supraventricular Tachycardia |
4.2% |
|
| Drug Exposure During Pregnancy |
9.1% |
| Renal Failure Acute |
9.1% |
| Coma Scale Abnormal |
4.5% |
| Death |
4.5% |
| Diabetic Ketoacidosis |
4.5% |
| Drug Ineffective |
4.5% |
| Fatigue |
4.5% |
| Heart Rate Decreased |
4.5% |
| Lichenoid Keratosis |
4.5% |
| Maternal Drugs Affecting Foetus |
4.5% |
| Movement Disorder |
4.5% |
| No Therapeutic Response |
4.5% |
| Overdose |
4.5% |
| Product Substitution Issue |
4.5% |
| Raynaud's Phenomenon |
4.5% |
| Reaction To Azo-dyes |
4.5% |
| Supraventricular Extrasystoles |
4.5% |
| Unresponsive To Stimuli |
4.5% |
| Visual Impairment |
4.5% |
| Wrong Drug Administered |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
34.7% |
| Hypertension |
19.7% |
| Drug Exposure During Pregnancy |
6.2% |
| Anaesthesia |
5.7% |
| Pre-eclampsia |
5.2% |
| Convulsion |
3.6% |
| Blood Pressure Abnormal |
3.1% |
| Coronary Artery Disease |
3.1% |
| Hepatitis C |
3.1% |
| Drug Use For Unknown Indication |
2.1% |
| Haemolytic Uraemic Syndrome |
2.1% |
| General Anaesthesia |
1.6% |
| Metastatic Renal Cell Carcinoma |
1.6% |
| Multiple Sclerosis |
1.6% |
| Pain |
1.6% |
| Diuretic Therapy |
1.0% |
| Fluid Retention |
1.0% |
| Induction Of Anaesthesia |
1.0% |
| Intentional Overdose |
1.0% |
| Overdose |
1.0% |
|
| Completed Suicide |
17.6% |
| Renal Failure Acute |
13.7% |
| Premature Baby |
11.8% |
| Toxicity To Various Agents |
7.8% |
| Blood Potassium Increased |
5.9% |
| Stress |
5.9% |
| Cardiac Arrest |
3.9% |
| Drug Ineffective |
3.9% |
| Orthostatic Hypotension |
3.9% |
| Visual Impairment |
3.9% |
| Weight Decreased |
3.9% |
| Blood Pressure Inadequately Controlled |
2.0% |
| Dizziness |
2.0% |
| Drug Dispensing Error |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Exposure During Pregnancy |
2.0% |
| Exposure Via Ingestion |
2.0% |
| Headache |
2.0% |
| Hypertension |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.5% |
| Hypertension |
18.6% |
| Pain |
3.9% |
| Blood Pressure Abnormal |
2.8% |
| Diabetes Mellitus |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Blood Pressure |
2.6% |
| Blood Cholesterol Increased |
2.2% |
| Coronary Artery Bypass |
2.0% |
| Anxiety |
1.9% |
| Depression |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Prophylaxis |
1.6% |
| Nausea |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Atrial Fibrillation |
1.3% |
| Renal Transplant |
1.3% |
| Cardiopulmonary Bypass |
1.2% |
|
| Weight Decreased |
9.0% |
| Vomiting |
7.1% |
| Myocardial Infarction |
6.2% |
| Pain |
6.2% |
| Death |
5.7% |
| Rhabdomyolysis |
5.7% |
| Weight Increased |
5.2% |
| Oedema Peripheral |
4.8% |
| Pain In Extremity |
4.8% |
| Respiratory Failure |
4.8% |
| Unevaluable Event |
4.8% |
| Urinary Tract Infection |
4.8% |
| Premature Baby |
4.3% |
| Rash |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Depression |
3.8% |
| Diarrhoea |
3.8% |
| Pulmonary Embolism |
3.8% |
| Cardiac Failure Congestive |
3.3% |
| Drug Interaction |
3.3% |
|
| Interacting |
| Hypertension |
45.5% |
| Goitre |
18.2% |
| Product Used For Unknown Indication |
18.2% |
| Erectile Dysfunction |
9.1% |
| Glaucoma |
9.1% |
|
| Throat Irritation |
50.0% |
| Erectile Dysfunction |
25.0% |
| Hypotension |
25.0% |
|
